Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Can Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Hit Three For Three Tomorrow?

- July 20, 2016
eli Lilly

Large and Small: Here’s What’s Moving Eli Lilly and Zosano

Amgen, Inc. (NASDAQ:AMGN) Partners With Nuevolution

Delving Into Seattle Genetics, Inc. (NASDAQ:SGEN)’s Upcoming Readout

pfizer-inc

Pfizer Inc. (NYSE:PFE) Buys 50% Stake In Ignite Immunotherapy

Here Are Two Dates To Watch In Biotech This October

- October 5, 2016 0
Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Agrees To Settle With The SEC...

- December 28, 2016 0
Atara

Atara’s Discontinuation Paints it as a Potential Short

- December 15, 2015 0

Here’s What’s Moving Novartis AG (ADR) (NYSE:NVS) and Kamada Ltd (NASDAQ:KMDA)

- June 23, 2017 0
sanofi

Sanofi SA (NYSE:SNY) Consolidates Its Distribution Network In Brazil To Incorporate...

Andy Parker - December 16, 2016 0

ICON PLC (NASDAQ:ICLR), Pfizer, Inc. (NYSE:PFE) Renew Partnership Agreement

- June 16, 2016 0

AstraZeneca Plc (ADR) (NYSE:AZN) Latest Initiative To House 2 Million Genomes

Andy Parker - April 26, 2016 0
Mylan NV

Mylan NV (NASDAQ:MYL), AbbVie Inc (NYSE:ABBV) Sanofi SA (NYSE:SNY) In Spotlight...

Andy Parker - January 3, 2017 0

AstraZeneca Plc (NYSE:AZN) Unveils Positive SOLO-2 Data

- October 27, 2016 0
AbbVie Inc

Emergent Technologies’ Pure MHC Explores A New Collaboration With AbbVie Inc...

Andy Parker - January 10, 2017 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 26, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 4, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 15, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019